Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
WM-115 | Vemurafenib | (+)-JQ1 | 0.100 | 1.000 | uM | 72 | hr | 2 | 1817 | 782 | 0.3175 | 0.3130 | 0.4304 | 0.4335 |
WM-115 | Vemurafenib | I-BET151 | 1.000 | 1.000 | uM | 72 | hr | 3 | 1516 | 654 | 0.2471 | 0.2677 | 0.4314 | 0.4255 |
COLO 858 | Vemurafenib | Belinostat | 1.000 | 0.000 | uM | 72 | hr | 3 | 1975 | 853 | 0.2574 | 0.2144 | 0.4319 | 0.4251 |
MMAC-SF | Vemurafenib | Defactinib | 3.160 | 3.160 | uM | 72 | hr | 2 | 414 | 180 | 0.1442 | 0.1471 | 0.4348 | 0.4142 |
A-375 | Vemurafenib | Belinostat | 0.316 | 1.000 | uM | 72 | hr | 3 | 1432 | 626 | 0.0615 | 0.0676 | 0.4372 | 0.4031 |
COLO 858 | Vemurafenib | I-BET151 | 1.000 | 0.000 | uM | 72 | hr | 2 | 1148 | 502 | 0.1493 | 0.1445 | 0.4373 | 0.4584 |
COLO 858 | Vemurafenib | (+)-JQ1 | 1.000 | 0.000 | uM | 72 | hr | 3 | 1602 | 701 | 0.2735 | 0.2031 | 0.4376 | 0.4582 |
COLO 858 | Vemurafenib | JNK-IN-8 | 1.000 | 0.000 | uM | 72 | hr | 1 | 1470 | 646 | 0.1366 | 0.1323 | 0.4395 | 0.4743 |
MMAC-SF | Vemurafenib | Dasatinib | 3.160 | 0.000 | uM | 72 | hr | 3 | 664 | 293 | 0.2841 | 0.2946 | 0.4413 | 0.4049 |
COLO 858 | Vemurafenib | Defactinib | 0.000 | 3.160 | uM | 72 | hr | 1 | 1609 | 714 | 0.1063 | 0.1023 | 0.4438 | 0.4297 |
WM-115 | Vemurafenib | JNK-IN-8 | 1.000 | 3.160 | uM | 72 | hr | 2 | 1864 | 831 | 0.2613 | 0.2705 | 0.4458 | 0.4169 |
A-375 | Vemurafenib | (+)-JQ1 | 1.000 | 1.000 | uM | 72 | hr | 3 | 1434 | 640 | 0.0562 | 0.0702 | 0.4463 | 0.4350 |
A-375 | Vemurafenib | (+)-JQ1 | 1.000 | 1.000 | uM | 72 | hr | 1 | 1979 | 884 | 0.0774 | 0.0702 | 0.4467 | 0.4350 |
COLO 858 | Vemurafenib | (+)-JQ1 | 1.000 | 0.000 | uM | 72 | hr | 2 | 1215 | 551 | 0.2016 | 0.2031 | 0.4535 | 0.4582 |
COLO 858 | Vemurafenib | I-BET151 | 1.000 | 0.000 | uM | 72 | hr | 1 | 1055 | 482 | 0.1324 | 0.1445 | 0.4569 | 0.4584 |
WM-115 | Vemurafenib | (+)-JQ1 | 0.100 | 1.000 | uM | 72 | hr | 3 | 1722 | 787 | 0.2869 | 0.3130 | 0.4570 | 0.4335 |
COLO 858 | Vemurafenib | I-BET | 1.000 | 0.000 | uM | 72 | hr | 1 | 916 | 420 | 0.1516 | 0.1880 | 0.4585 | 0.4335 |
MMAC-SF | Vemurafenib | Defactinib | 1.000 | 3.160 | uM | 72 | hr | 3 | 475 | 218 | 0.1583 | 0.1742 | 0.4589 | 0.4178 |
MMAC-SF | Vemurafenib | Defactinib | 3.160 | 0.000 | uM | 72 | hr | 2 | 706 | 324 | 0.2354 | 0.2403 | 0.4589 | 0.4433 |
COLO 858 | Vemurafenib | Saracatinib | 0.316 | 0.316 | uM | 72 | hr | 3 | 1431 | 657 | 0.1311 | 0.1170 | 0.4591 | 0.4614 |
COLO 858 | Vemurafenib | (+)-JQ1 | 0.000 | 1.000 | uM | 72 | hr | 2 | 904 | 415 | 0.1484 | 0.1822 | 0.4591 | 0.4375 |
MMAC-SF | Vemurafenib | PF562271 | 3.160 | 3.160 | uM | 72 | hr | 3 | 196 | 90 | 0.1073 | 0.1255 | 0.4592 | 0.4181 |
COLO 858 | Vemurafenib | Dasatinib | 1.000 | 0.000 | uM | 72 | hr | 3 | 2014 | 926 | 0.1554 | 0.1375 | 0.4598 | 0.4603 |
COLO 858 | Vemurafenib | Defactinib | 0.316 | 1.000 | uM | 72 | hr | 1 | 1692 | 781 | 0.1082 | 0.1083 | 0.4616 | 0.4526 |
COLO 858 | Vemurafenib | Belinostat | 1.000 | 0.000 | uM | 72 | hr | 2 | 1665 | 769 | 0.2056 | 0.2144 | 0.4619 | 0.4251 |